No Data
No Data
SMN: Interim report - 28th period (2024/04/01 - 2025/03/31)
SMN: (Progress of disclosure matters) Notice regarding determination of the recorded amount of special profit associated with the transfer of subsidiary shares, recording exchange losses (non-operating expenses), and revisions to earnings f...
SMN: Presentation of financial results for the 2nd quarter of the fiscal year ending March 31, 2025
SMN: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (consolidated)
Daiichi Sankyo, Fujitsu, JR East Japan, ANA (31st)
※The above calendar is subject to change depending on the company's schedule.---------------------------------------October 31st (Thursday) ＜1777＞Kawasaki Facilities ＜1798＞Morita Shokai ＜1911＞Sumitomo-Rin ＜1934＞Yuatec ＜1939＞Yondenko ＜1941＞Chudenko ＜1942＞Kandenko ＜1944＞Kinden ＜194
Kufu Company, Helios, and others.
＜156A＞ Matelial G completes the acquisition of its own shares. ＜3690＞ Ilgulum downwardly revised, the expected operating profit for the current year is ¥0.14 billion, a decrease of ¥0.24 billion. Dividends for the end of this term will be ¥7.60 per share, down from ¥7.90. ＜6185＞ fully acquired all the shares of Ruby Group, a subsidiary company. ＜4376＞ Kufu Company completes the acquisition of its own shares. ＜4593＞ Helios and other non-home iPS cells derived from retinal pigment epithelial cells (HLCR011) targeting retinal pigment epithelial holes.
No Data
No Data